Topics
Glioblastoma | Treatment | Chemotherapy | Temozolomide | Resistance
Home > Publications > Topics > Glioblastoma > Treatment > Chemotherapy > Temozolomide > Resistance
*Karve AS, Desai JM, Gadgil SN, Dave N, Wise-Draper TM, Gudelsky
GA, Phoenix TN, DasGupta B, Yogendran L, Sengupta S, Plas DR,
Desai PB.
A Review of Approaches to
Potentiate the Activity of Temozolomide against Glioblastoma to
Overcome Resistance.
Int
J Mol Sci. 2024 Mar 12;25(6):3217. doi:
10.3390/ijms25063217. PMID:
38542190. Review. ˍ
Smerdi D, Moutafi M, Kotsantis I,
Stavrinou LC, Psyrri A.
Overcoming
Resistance to Temozolomide in Glioblastoma: A Scoping Review of
Preclinical and Clinical Data.
Life
(Basel). 2024 May 24;14(6):673. doi:
10.3390/life14060673. PMID:
38929657.
Review.
ˍ
Miramova A, Gartner A, Ivanov D.
How
to sensitize glioblastomas to
temozolomide chemotherapy: a
gap-centered view.
Front
Cell Dev Biol. 2024 Jul 1;12:1436563. doi:
10.3389/fcell.2024.1436563. PMID:
39011394. Review. ˍ